HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

48 hedge funds and large institutions have $56.7M invested in abrdn Life Sciences Investors in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less capital invested

Capital invested by funds: $65M → $56.7M (-$8.29M)

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.09M
2
+$812K
3
+$724K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$671K
5
Citigroup
Citigroup
New York
+$619K

Top Sellers

1
-$470K
2
-$375K
3
-$347K
4
CL
CSS LLC
Illinois
-$307K
5
AAM
Advisors Asset Management
Colorado
-$278K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$295K
27
$289K
28
$275K
29
$235K
30
$200K
31
$118K
32
$109K
33
$73K
34
$45K
35
$38K
36
$32K
37
$24K
38
$22K
39
$22K
40
$19K
41
$10K
42
$1K
43
$1K
44
$1K
45
–
46
–
47
–
48
–
49
–
1
2